Concern for MAS is particularly high in patients with ferritin levels elevated out of proportion to other inflammatory markers, lymphadenopathy, weight loss, transaminase elevation, hepatomegaly, marked elevation in D-dimer, thrombocytopenia, and/or a decreasing erythrocyte sedimentation rate despite continued elevation of C-reactive protein [14]. This evidence concerns the gene CRP and Lymphadenopathy.